Literature DB >> 1984653

Linker mutation scanning of the genes encoding the adenovirus type 5 terminal protein precursor and DNA polymerase.

D J Roovers1, P F Overman, X Q Chen, J S Sussenbach.   

Abstract

The replication of adenovirus DNA requires, in addition to several host factors, three virus-encoded proteins: a DNA binding protein, the precursor of the terminal protein (pTP), and a DNA polymerase (Ad pol). Ad pol and pTP form a tight complex that is necessary for the initiation step in DNA replication. To perform mutation scanning of the adenovirus type 5 pTP and Ad pol a series of in-frame linker insertions of a 12-mer oligonucleotide d(CCCATCGATGGG) were introduced into cloned viral DNA fragments containing coding sequences of these proteins. The insertions are located at recognition sites for several blunt end-cutting restriction endonucleases. Forty different sites were mutagenized and the mutated genes were transferred to a plasmid that contains the left 42% of the adenovirus genome. They were rebuilt into the viral genome by means of in vivo recombination between plasmid DNA and digested adenovirus DNA-TP complex. The resulting viral genomes were tested for viability and rescued virus was analyzed for the presence of the inserted linker oligonucleotide. This procedure resulted in recovery of a number of viable virus mutants with insertions in the pTP or Ad pol genes, all of which are phenotypically silent. The other mutations did not allow virus production. The positions of these apparent lethal codon insertion mutations were useful to identify regions of functional importance in both proteins. It can be concluded that the precursor-specific region of pTP plays an important role in virus multiplication.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1984653     DOI: 10.1016/0042-6822(91)90032-7

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  16 in total

1.  DNA sequence analysis of an avian adenovirus terminal protein precursor.

Authors:  R J McCoy; M Sheppard
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

2.  Adenovirus homologous recombination does not require expression of the immediate-early E1a gene.

Authors:  L H Epstein; C S Young
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

3.  Linker insertion mutations in the adenovirus preterminal protein that affect DNA replication activity in vivo and in vitro.

Authors:  J N Fredman; S C Pettit; M S Horwitz; J A Engler
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

4.  Adenovirus DNA replication: the function of the covalently bound terminal protein.

Authors:  R Pronk; M H Stuiver; P C van der Vliet
Journal:  Chromosoma       Date:  1992       Impact factor: 4.316

5.  Adenovirus DNA polymerase: domain organisation and interaction with preterminal protein.

Authors:  E J Parker; C H Botting; A Webster; R T Hay
Journal:  Nucleic Acids Res       Date:  1998-03-01       Impact factor: 16.971

6.  Domain organization of the adenovirus preterminal protein.

Authors:  A Webster; I R Leith; R T Hay
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

7.  Role of preterminal protein processing in adenovirus replication.

Authors:  A Webster; I R Leith; J Nicholson; J Hounsell; R T Hay
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

8.  The adenovirus terminal protein influences binding of replication proteins and changes the origin structure.

Authors:  R Pronk; P C van der Vliet
Journal:  Nucleic Acids Res       Date:  1993-05-25       Impact factor: 16.971

9.  Molecular architecture of adenovirus DNA polymerase and location of the protein primer.

Authors:  Arjan B Brenkman; Elise C Breure; Peter C van der Vliet
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

10.  Polymerization activity of an alpha-like DNA polymerase requires a conserved 3'-5' exonuclease active site.

Authors:  J S Gibbs; K Weisshart; P Digard; A deBruynKops; D M Knipe; D M Coen
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.